AG-019

N/A

Report date: 2023/04/04 16:57:20

Base Information

Drug NameAG-019
Drug Alias NameAG-019
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin 10 receptor stimulantsGene transference
TargetsInterleukin 10 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrecigen Actobio Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntrexon Actobiotics Nv, D/B/A Precigen ActobioPrecigen Actobio T1d LlcIntrexon Corporation
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A